Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

New hires at Merck KGaA's neurology & immunology business; plus Repertoire, Kinnate, Allakos, Intercept and more

June 7, 2021 11:14 PM UTC

Amy Mahery, a 17-year veteran at Merck KGaA (Xetra:MRK), was named the pharma’s SVP and head of the neurology and immunology global business franchise; she was SVP and head of global market access and pricing. Merck KGaA also hired Jan Klatt as SVP and head of development at neurology and immunology unit and said Amy Kao will transition to head of translational innovation platform immunology from her role as head of global clinical development in Immunology. Klatt was global program head of heart failure at Novartis AG (NYSE:NVS; SIX:NOVN). 

Repertoire Immune Medicines Inc. hired Anne Walker as EVP and CFO, Theodore Reiss as EVP and CMO and Jorg Thommes as EVP of pharmaceutical sciences and operations. Walker joins the immune medicines company from Bank of America, where she was global real estate and strategic initiatives executive. Reiss was a venture partner at Novo Ventures, and Thommes was head of CMC at Bill & Melinda Gates Medical Research Institute...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article